Methasterone (Superdrol)

Methasterone (Superdrol) | NexorinPharma

Methasterone is an oral anabolic steroid containing Methasterone per tablet. At NexorinPharma, we carry Methasterone as part of our oral anabolic steroid inventory for customers in markets where Methasterone is legally available.

Methasterone is the active compound in this preparation, widely known under the brand name Superdrol. It is one of the most potent oral anabolic steroids discussed in performance communities and carries a correspondingly serious side effect profile. Unlike many anabolic steroids discussed in performance communities, Methasterone has a relatively recent history, having been introduced to the market in the early 2000s as a designer steroid before regulatory classification.

This page covers what Methasterone is, how it works, and what health and legal considerations apply. It does not constitute medical advice, recommend steroid use, or provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

What Is Methasterone

Methasterone is a synthetic anabolic-androgenic steroid derived from Dihydrotestosterone. It is structurally related to Drostanolone, differing by the addition of a methyl group at the 17-alpha position that allows oral bioavailability. This structural modification allows Methasterone to survive first-pass liver metabolism when taken orally, consequently placing it in the same 17-alpha alkylated category as most other oral anabolic steroids.

Methasterone was originally developed in the 1950s by Syntex alongside other DHT derivatives but was never introduced as a pharmaceutical product. It resurfaced in the early 2000s when Designer Supplements marketed it as a dietary supplement under the brand name Superdrol, exploiting a regulatory gap that classified it as a nutritional supplement rather than a controlled substance. The FDA and DEA subsequently took regulatory action, and the Anabolic Steroid Control Act of 2014 consequently classified Methasterone as a Schedule III controlled substance.

Structurally, Methasterone carries an anabolic rating of 400 and an androgenic rating of only 20 relative to a testosterone baseline of 100. This produces one of the highest anabolic-to-androgenic ratios among oral anabolic steroids. The compound does not aromatize to estrogen and does not convert through the conventional 5-alpha reductase pathway. As a result, its pharmacological profile is distinct from most other oral anabolic steroids in both its potency and its side effect considerations.

How Methasterone Works

Methasterone is active when taken orally. The 17-alpha alkylation allows it to pass through the liver without complete breakdown, reaching systemic circulation in active form.

Androgen Receptor Binding

Methasterone binds to androgen receptors throughout the body with high affinity despite its low androgenic rating of 20. Its anabolic rating of 400 reflects its strong anabolic receptor binding activity relative to its androgenic activity. As a result, androgen receptor activation in muscle tissue drives its pronounced anabolic effects while producing comparatively minimal androgenic activity in androgen-sensitive tissues.

Nitrogen Retention

Methasterone produces very strong positive nitrogen retention in muscle tissue. The body retains significantly more nitrogen than it excretes. Consequently, this produces a pronounced anabolic environment that strongly favors rapid muscle repair and growth. This mechanism is one of the most consistently referenced pharmacological characteristics of Methasterone in performance community discussions.

Protein Synthesis

Methasterone accelerates protein synthesis in skeletal muscle tissue at a rate consistent with its high anabolic rating of 400. Faster protein synthesis supports rapid muscle repair and growth following training. This mechanism is directly tied to its androgen receptor activity and consequently contributes to the rapid strength and mass observations consistently reported in performance community discussions about Methasterone use.

No Aromatization

Methasterone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase, and estrogen-related side effects including water retention and gynecomastia are therefore not part of its direct pharmacological profile. This non-aromatizing characteristic is one of the most consistently referenced distinctions of Methasterone compared to aromatizing oral anabolic steroids.

No Progestogenic Activity

Methasterone does not show clinically significant affinity for progesterone receptors, which distinguishes it from compounds like Trenbolone and Nandrolone where progestogenic activity is a primary side effect consideration. As a result, Methasterone carries a cleaner hormonal side effect profile in terms of estrogenic and progestogenic activity compared to progestogenic anabolic steroids.

IGF-1 Stimulation

Methasterone increases Insulin-like Growth Factor 1 production. IGF-1 plays a direct role in muscle repair, recovery, and anabolic activity throughout the body. This mechanism consequently contributes to the recovery and strength-related observations consistently reported in performance community discussions about Methasterone use.

Why Methasterone Is Discussed in Performance Communities

Methasterone generates consistent discussion in bodybuilding and performance communities. Several specific characteristics drive that discussion.

High Anabolic-to-Androgenic Ratio

Methasterone’s anabolic rating of 400 combined with its androgenic rating of only 20 produces one of the highest anabolic-to-androgenic ratios among oral anabolic steroids. This profile drives its discussion among individuals seeking strong anabolic activity with minimal androgenic side effect considerations. As a result, it is consistently referenced in performance communities alongside compounds like Oxandrolone for its favorable ratio between anabolic and androgenic activity.

Non-Aromatizing Profile

Methasterone’s complete resistance to aromatization means it does not directly produce estrogenic side effects. This non-aromatizing characteristic consequently drives consistent discussion in performance communities among individuals seeking anabolic activity without the estrogenic side effect management requirements associated with aromatizing compounds.

Dry Appearance Effect

Methasterone’s non-aromatizing profile and the absence of water retention from estrogenic activity contribute to the dry, hard appearance observations consistently discussed in performance communities. This aesthetic characteristic consequently drives specific discussion of Methasterone in body composition and contest preparation contexts where minimizing water retention is a primary consideration.

Oral Format Convenience

The oral tablet format of Methasterone is a practical consideration that drives discussion compared to injectable anabolic steroids requiring intramuscular administration. The oral format eliminates injection site considerations and simplifies administration compared to injectable alternatives. As a result, it remains a consistently discussed option in performance communities where oral administration preference is relevant.

Methasterone Versus Other Oral Anabolic Steroids

Versus Oxymetholone (Anadrol)

Oxymetholone is one of the few oral anabolic steroids carrying comparable anabolic potency to Methasterone. Oxymetholone produces significant estrogenic effects despite not directly aromatizing, while Methasterone produces no estrogenic activity whatsoever. Both carry severe liver toxicity as 17-alpha alkylated compounds. Methasterone consequently produces a drier overall profile than Oxymetholone due to the absence of estrogenic water retention.

Versus Methandrostenolone (Dianabol)

Methandrostenolone aromatizes significantly to estrogen and carries a lower anabolic rating than Methasterone. Methasterone, by contrast, produces no estrogenic conversion and carries a significantly higher anabolic rating of 400 compared to Methandrostenolone’s 90 to 210. Both are 17-alpha alkylated with significant liver toxicity. Methasterone consequently represents a significantly more potent and drier pharmacological profile than Methandrostenolone across all relevant parameters.

Versus Stanozolol (Winstrol)

Stanozolol is a non-aromatizing oral anabolic steroid with significant liver toxicity from 17-alpha alkylation, and both Methasterone and Stanozolol are non-aromatizing DHT-derived compounds. However, Methasterone carries a significantly higher anabolic rating of 400 compared to Stanozolol’s approximately 320. Both consequently carry significant hepatotoxicity, though Methasterone’s liver toxicity profile is generally considered more severe.

Versus Oxandrolone (Anavar)

Oxandrolone is one of the mildest oral anabolic steroids with significantly lower liver toxicity than Methasterone. Both are non-aromatizing compounds. However, Methasterone carries a significantly higher anabolic rating and a considerably more severe liver toxicity profile than Oxandrolone. Furthermore, Oxandrolone carries active FDA approval while Methasterone has no approved clinical indication. These two compounds consequently occupy fundamentally different positions on the oral anabolic steroid potency and risk spectrum.

Versus Fluoxymesterone (Halotestin)

Fluoxymesterone carries anabolic and androgenic ratings of 1900 and 1600 respectively, making it the more potent compound in terms of raw receptor binding ratings. Methasterone, on the other hand, carries a significantly higher anabolic-to-androgenic ratio of 400 to 20 compared to Fluoxymesterone’s more balanced ratio. Both carry severe liver toxicity. Fluoxymesterone’s extreme androgenic potency consequently produces more pronounced androgenic side effects than Methasterone at comparable doses.

Side Effects and Health Risks

Methasterone carries one of the most serious side effect profiles of any oral anabolic steroid discussed in performance communities. These risks are well-documented in case reports and community observational data and cannot be minimized in any responsible discussion of this compound.

Liver Toxicity

Liver toxicity is the most serious health concern associated with Methasterone use. As a 17-alpha alkylated oral steroid, the alkylation that allows oral bioavailability places severe and direct stress on liver tissue. Methasterone’s liver toxicity is consequently considered among the most severe of any commonly discussed oral anabolic steroid, exceeding even the significant hepatotoxicity associated with Methandrostenolone and approaching the severity documented with Oxymetholone. Case reports document serious hepatic complications including cholestatic hepatitis, peliosis hepatis, and in severe cases liver failure. Liver monitoring through regular blood work is therefore absolutely essential for anyone using this compound.

Cardiovascular Effects

Methasterone produces severe adverse lipid profile changes. HDL cholesterol drops dramatically while LDL cholesterol increases substantially. These lipid changes are among the most severe of any oral anabolic steroid and carry serious long-term cardiovascular health implications. Furthermore, elevated blood pressure is consistently reported with Methasterone use in performance community discussions. Regular cardiovascular monitoring is therefore essential for anyone using this compound.

Hormonal Suppression

Methasterone suppresses the hypothalamic-pituitary-gonadal axis and the body’s natural testosterone production. Post-use hormonal disruption can persist for months and in some cases results in long-term or permanent hypogonadism requiring ongoing medical treatment. Hormonal monitoring is consequently a relevant health consideration for anyone using this compound.

Androgenic Effects

Despite its very low androgenic rating of 20, Methasterone still produces androgenic side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals and acne on the face and back. In women, virilization risks remain relevant even with lower-androgenic compounds and consequently represent a serious consideration.

Lethargy and Fatigue

Lethargy, fatigue, and decreased energy levels are among the most consistently reported immediate side effects of Methasterone use in performance community discussions. These effects are more pronounced than with most other oral anabolic steroids and represent a primary practical consideration with Methasterone use. As a result, anyone using Methasterone should be aware of these fatigue-related effects before proceeding.

Psychological Effects

Anabolic steroid use carries documented associations with mood changes and irritability. These considerations apply to Methasterone use. The combination of significant HPG axis suppression and liver stress from Methasterone use consequently contributes to mood and psychological effects that are more pronounced than with milder anabolic steroids.

Legal and Regulatory Status

Methasterone carries Schedule III controlled substance status in the United States under the Anabolic Steroid Control Act of 2014. This scheduling followed its use as a designer supplement under the Superdrol brand name in the early 2000s. Possession without a valid prescription is consequently a federal offense.

In the United Kingdom, Methasterone falls under Class C of the Misuse of Drugs Act. Supply is illegal.

The World Anti-Doping Agency bans Methasterone alongside all major athletic governing bodies. As a result, it appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Methasterone in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Methasterone Available at NexorinPharma

Yes. NexorinPharma carries Methasterone for customers in markets where Methasterone is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Is the Half-Life of Methasterone

Methasterone produces a half-life of approximately 6 to 8 hours. As a result, regular daily administration is required to maintain stable plasma concentrations throughout the day.

Does Methasterone Aromatize

No. Methasterone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase, and estrogen-related side effects are consequently not part of its direct pharmacological profile.

How Does Methasterone Differ From Superdrol

Methasterone and Superdrol refer to the same active compound. Superdrol is the brand name under which Methasterone was originally marketed as a dietary supplement before its classification as a controlled substance. The active compound is consequently identical regardless of the specific brand name used.

What Makes Methasterone Different From Other Oral Anabolic Steroids

Methasterone’s primary distinguishing characteristics are its extremely high anabolic-to-androgenic ratio of 400 to 20, its complete non-aromatizing profile, its severe liver toxicity, and the lethargy and fatigue consistently reported with its use. These characteristics consequently place it among the most potent and highest-risk oral anabolic steroids available.

What Are the Most Serious Health Risks

Severe liver toxicity is the most serious health concern with Methasterone, representing one of the most significant hepatotoxicity profiles among commonly discussed oral anabolic steroids. In addition, severe cardiovascular lipid dysregulation, hormonal suppression, lethargy, and psychological effects complete the primary risk profile. Medical supervision and regular blood work monitoring are therefore absolutely essential for anyone using this compound.

Is Methasterone Legal to Purchase

Methasterone carries Schedule III controlled substance status in the United States. Legal status varies by jurisdiction. You are consequently responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Methasterone

Methasterone does not carry an approved clinical indication and consequently lacks the clinical research base that compounds like Oxandrolone, Oxymetholone, or Methandrostenolone carry. Its research base derives primarily from case reports, community observational data, and pharmacological analysis rather than controlled clinical trials. This absence of clinical research context makes evaluating its complete risk profile more challenging than with compounds carrying documented clinical histories.

Non-prescription Methasterone preparations do not carry the manufacturing oversight of pharmaceutical grade products. Quality, purity, and concentration accuracy are consequently less verifiable than with regulated products. Furthermore, the case report literature for Methasterone documents serious hepatic complications that place its liver toxicity profile among the most severe of any commonly discussed oral anabolic steroid.

Methasterone carries documented severe liver, cardiovascular, hormonal, androgenic, and psychological health risks. These risks require medical supervision to manage responsibly. Regular blood work monitoring including liver enzymes, lipid panels, hematocrit, and hormone levels is therefore absolutely essential for anyone using this compound.

For customers in markets where Methasterone is legally available, visit nexorinpharma.com to check current Methasterone availability, pricing, and stock levels.